AI
Monday, December 02, 2024 8:00:56 AM
A genetic subgroup, COL24A1, covering nearly half of the patient population, has been shown to slow Alzheimer's progression by 65-75%, effectively halting progression for many patients. This could potentially extend the average lifespan for individuals in this group by 20 years—a truly revolutionary breakthrough. The company should consider issuing a press release along with OLE before CM's discussion with BP on Wednesday to ensure this game-changing finding is highlighted.
